A poster presentation at JADPRO Live 2022 described the benefits of using simulation training in combination with didactic educational sessions to improve knowledge and confidence for bone marrow transplant APPs.
Multiple myeloma is an uncommon form of cancer, and one that may not produce symptoms right away. Because of this, patients with higher risk due to family history, exposure, or other reasons may need more education about it. How can you explain multiple myeloma to your patients?
AML survivors treated with blood or marrow transplantation have a greater risk of grade 3 or higher chronic health conditions, according to a survey that compared the long-term outcomes between survivors and their healthy siblings.
Researchers sought to determine whether late mortality rates are affected by exposure to a BCR-ABL TKI prior to BMT in patients with CML who survive at least 2 years posttransplantation.
ECIL 7 releases its guidelines for managing CMV infection in patients with hematologic malignancies and after HSCT.
A novel agent, letermovir, reduced incidence of CMV in patients undergoing stem cell transplantation for hematologic malignancies.
New research has shed light on how the blood is produced in the body, and this work, done in mice, moves science a step closer to manipulation of blood stem cell creation. This could reduce the need for bone marrow transplants, such as those needed by patients with cancer.
Hematopoietic cell transplantation (HCT)-related concerns at the time of hospital discharge predict increases in depression but not in anxiety.
Psychosocial support for donor siblings of bone marrow transplant patients is a significant part of the care provided by the transplant team.
Blocking the passage of immune cells could prevent dangerous complications in patients undergoing transplants or chemotherapy.
